back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-06-04 16:25 Tx date 2026-06-01 |
$ONCY
Oncolytics Biotech Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$31,800
+30,000 vol $1.06 each |
285,000 | |
| Filed 2026-06-04 10:29 Tx date 2026-06-01 |
$DMAC
DiaMedica Therapeutics Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+51,189 vol |
193,316 | |
| Filed 2026-04-17 16:13 Tx date 2026-01-02 |
$DMAC
DiaMedica Therapeutics Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+10,095 vol |
83,699 | |
| Filed 2026-04-17 16:12 Tx date 2025-01-02 |
$DMAC
DiaMedica Therapeutics Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+15,917 vol |
73,604 | |
| Filed 2026-04-17 16:12 Tx date 2024-01-02 |
$DMAC
DiaMedica Therapeutics Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+21,428 vol |
57,687 | |
| Filed 2026-04-17 16:10 Tx date 2025-06-01 |
$DMAC
DiaMedica Therapeutics Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,739 vol |
142,127 | |
| Filed 2026-04-15 11:53 Tx date 2026-04-14 |
$SVA
Sernova Biotherapeutics Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+114,939 vol |
229,877 | |
| Filed 2026-04-15 11:49 Tx date 2026-04-14 |
$SVA
Sernova Biotherapeutics Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+114,938 vol |
114,938 | |
| Filed 2026-04-15 11:32 Tx date 2026-04-14 |
$SVA
Sernova Biotherapeutics Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$43,676
+229,877 vol $0.19 each |
614,605 | |
| Filed 2026-03-13 09:06 Tx date 2026-03-11 |
$ONCY
Oncolytics Biotech Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,300
+10,000 vol $1.03 each |
41,849 | |
| Filed 2026-03-04 11:28 Tx date 2026-03-03 |
$SVA
Sernova Biotherapeutics Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
$-30,000
-100,000 vol $0.30 each |
0 | |
| Filed 2026-02-27 15:33 Tx date 2026-02-24 |
$SVA
Sernova Biotherapeutics Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$90,000
+600,000 vol $0.15 each |
7,320,000 | |
| Filed 2026-02-27 15:31 Tx date 2026-02-24 |
$SVA
Sernova Biotherapeutics Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$120,000
+400,000 vol $0.30 each |
6,720,000 | |
| Filed 2026-02-27 15:30 Tx date 2026-02-24 |
$SVA
Sernova Biotherapeutics Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$187,500
+1,250,000 vol $0.15 each |
6,320,000 | |
| Filed 2025-08-22 18:29 Tx date 2025-08-18 |
$ONC
Oncolytics Biotech Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$162,000
+150,000 vol $1.08 each |
255,000 | |
| Filed 2025-07-16 19:02 Tx date 2025-07-16 |
$ONC
Oncolytics Biotech Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+23,746 vol |
31,849 | |
| Filed 2025-07-16 19:01 Tx date 2025-07-16 |
$ONC
Oncolytics Biotech Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-23,746 vol |
0 | |
| Filed 2025-07-16 19:00 Tx date 2025-07-14 |
$ONC
Oncolytics Biotech Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+23,746 vol |
23,746 | |
| Filed 2025-06-04 11:31 Tx date 2025-06-01 |
$DMAC
DiaMedica Therapeutics Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,739 vol |
101,388 | |
| Filed 2025-04-22 18:38 Tx date 2025-04-21 |
$ONC
Oncolytics Biotech Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+8,103 vol |
8,103 |